Enclosed.

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.1%1-day move

₹131.60

prior close

₹132.60

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.7-2.0-1.0+0.2+4.1+3.6+0.4-4.4-8.2-6.5-7.7+0.7+1.1—

Up moveDown movePending

AI summary

Camlin Fine Sciences has filed a draft simplified cash tender offer with the French Stock Markets Authority (AMF) to acquire the remaining shares of Vinpai that it does not already own. The company initially acquired a majority stake (78.68% of share capital) in November 2025 at EUR 3.60 per share and now holds 83.82% after converting convertible bonds. The new tender offer targets the remaining shares at the same price of EUR 3.60 per share. An independent expert (Crowe HAF) has confirmed the offer is fair for minority shareholders, and Vinpai's Board has unanimously given a favorable opinion. Importantly, CFSL states it no longer intends to pursue a squeeze-out procedure.

Likely market impact

This acquisition move could be positive for CFSL shareholders as it strengthens control over Vinpai, though the market may watch for dilution risks or integration challenges with the French subsidiary.